Sign In to Follow Application
View All Documents & Correspondence

A Composition For Enhancing The Effect Of Chlorogenic Acid On The Inflammatory Response

Abstract: The present disclosure relates to a composition and method for modulating the inflammatory response. In particular, the present disclosure relates to a composition of chlorogenic acid, and vitamin D that enhances the effect of chlorogenic acid alone on modulating the inflammatory response. The present disclosure also provides a method, and food products, for modulating the physiological inflammatory response.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
18 November 2013
Publication Number
22/2015
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
lsmds@lakshmisri.com
Parent Application
Patent Number
Legal Status
Grant Date
2020-05-15
Renewal Date

Applicants

ITC LIMITED
ITC-LIFE SCIENCES AND TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058

Inventors

1. NARAYANAPERUMAL, Jeyaparthasarathy
Life Science and Technology Centre ITC Limited #3, 1st Main, Peenya Industrial Area, Phase I, Bangalore-560 058
2. SHEKHAR, Arvind Chandra
Life Science and Technology Centre ITC Limited #3, 1st Main, Peenya Industrial Area, Phase I, Bangalore-560 058
3. THAMBRAHALLI, Anathanag
Life Science and Technology Centre ITC Limited #3, 1st Main, Peenya Industrial Area, Phase I, Bangalore-560 058
4. SUJITH, Peter Amla
Life Science and Technology Centre ITC Limited #3, 1st Main, Peenya Industrial Area, Phase I, Bangalore-560 058
5. DIXIT, Ajay Kumar
Life Science and Technology Centre ITC Limited #3, 1st Main, Peenya Industrial Area, Phase I, Bangalore-560 058
6. GOPAL, Ganesh
Life Science and Technology Centre ITC Limited #3, 1st Main, Peenya Industrial Area, Phase I, Bangalore-560 058

Specification

CLIAMS:1. A composition comprising:
a. chlorogenic acid; and
b. vitamin D
wherein, said composition enhances the effect of chlorogenic acid on modulating the inflammatory response.
2. The composition as claimed in claim 1, wherein the concentration of chlorogenic acid is in the range of 5µM-100µM.
3. The composition as claimed in claim 2, wherein the concentration of chlorogenic acid is 50µM.
4. The composition as claimed in claim1, wherein the concentration of vitamin D is 1µM.
5. The composition as claimed in claim 1, wherein the molar ratio of chlorogenic acid to vitamin D is 100:1 to 1:1.
6. The composition as claimed in claim 5, wherein the molar ratio of chlorogenic acid to vitamin D is 50:1.
7. A food product comprising the composition as claimed in claim 1.
8. A method for modulating the inflammatory response, wherein said method comprises oral administration to a subject in need thereof an effective amount of said food product as claimed in claim 7.
9. The method as claimed in claim 8, wherein the oral administration can be in the form of a solid or a liquid. ,TagSPECI:As Attached

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 5311-CHE-2013-RELEVANT DOCUMENTS [14-08-2023(online)].pdf 2023-08-14
1 SPEC IN.pdf 2013-11-19
2 5311-CHE-2013-PETITION UNDER RULE 137 [18-11-2022(online)].pdf 2022-11-18
2 FORM 5.pdf 2013-11-19
3 FORM 3.pdf 2013-11-19
3 5311-CHE-2013-RELEVANT DOCUMENTS [18-11-2022(online)].pdf 2022-11-18
4 FIGURES IN.pdf 2013-11-19
4 5311-CHE-2013-Response to office action [18-11-2022(online)].pdf 2022-11-18
5 5311-CHE-2013-RELEVANT DOCUMENTS [29-09-2022(online)].pdf 2022-09-29
5 5311-CHE-2013 POWER OF ATTORNEY 06-02-2014.pdf 2014-02-06
6 5311-CHE-2013-Abstract_Granted 336909_15-05-2020.pdf 2020-05-15
6 5311-CHE-2013 FORM-1 06-02-2014.pdf 2014-02-06
7 5311-CHE-2013-Claims_Granted 336909_15-05-2020.pdf 2020-05-15
7 5311-CHE-2013 CORRESPONDENCE OTHERS 06-02-2014.pdf 2014-02-06
8 Form 18 [04-01-2017(online)].pdf 2017-01-04
8 5311-CHE-2013-Description_Granted 336909_15-05-2020.pdf 2020-05-15
9 5311-CHE-2013-Drawings_Granted 336909_15-05-2020.pdf 2020-05-15
9 5311-CHE-2013-FER.pdf 2018-10-30
10 5311-CHE-2013-IntimationOfGrant15-05-2020.pdf 2020-05-15
10 5311-CHE-2013-OTHERS [01-04-2019(online)].pdf 2019-04-01
11 5311-CHE-2013-FER_SER_REPLY [01-04-2019(online)].pdf 2019-04-01
11 5311-CHE-2013-Marked up Claims_Granted 336909_15-05-2020.pdf 2020-05-15
12 5311-CHE-2013-DRAWING [01-04-2019(online)].pdf 2019-04-01
12 5311-CHE-2013-PatentCertificate15-05-2020.pdf 2020-05-15
13 5311-CHE-2013-CORRESPONDENCE [01-04-2019(online)].pdf 2019-04-01
13 5311-CHE-2013-Written submissions and relevant documents (MANDATORY) [17-12-2019(online)].pdf 2019-12-17
14 5311-CHE-2013-CLAIMS [01-04-2019(online)].pdf 2019-04-01
14 5311-CHE-2013-Correspondence to notify the Controller (Mandatory) [02-12-2019(online)].pdf 2019-12-02
15 5311-CHE-2013-HearingNoticeLetter-(DateOfHearing-03-12-2019).pdf 2019-11-08
16 5311-CHE-2013-CLAIMS [01-04-2019(online)].pdf 2019-04-01
16 5311-CHE-2013-Correspondence to notify the Controller (Mandatory) [02-12-2019(online)].pdf 2019-12-02
17 5311-CHE-2013-Written submissions and relevant documents (MANDATORY) [17-12-2019(online)].pdf 2019-12-17
17 5311-CHE-2013-CORRESPONDENCE [01-04-2019(online)].pdf 2019-04-01
18 5311-CHE-2013-PatentCertificate15-05-2020.pdf 2020-05-15
18 5311-CHE-2013-DRAWING [01-04-2019(online)].pdf 2019-04-01
19 5311-CHE-2013-FER_SER_REPLY [01-04-2019(online)].pdf 2019-04-01
19 5311-CHE-2013-Marked up Claims_Granted 336909_15-05-2020.pdf 2020-05-15
20 5311-CHE-2013-IntimationOfGrant15-05-2020.pdf 2020-05-15
20 5311-CHE-2013-OTHERS [01-04-2019(online)].pdf 2019-04-01
21 5311-CHE-2013-Drawings_Granted 336909_15-05-2020.pdf 2020-05-15
21 5311-CHE-2013-FER.pdf 2018-10-30
22 5311-CHE-2013-Description_Granted 336909_15-05-2020.pdf 2020-05-15
22 Form 18 [04-01-2017(online)].pdf 2017-01-04
23 5311-CHE-2013 CORRESPONDENCE OTHERS 06-02-2014.pdf 2014-02-06
23 5311-CHE-2013-Claims_Granted 336909_15-05-2020.pdf 2020-05-15
24 5311-CHE-2013 FORM-1 06-02-2014.pdf 2014-02-06
24 5311-CHE-2013-Abstract_Granted 336909_15-05-2020.pdf 2020-05-15
25 5311-CHE-2013-RELEVANT DOCUMENTS [29-09-2022(online)].pdf 2022-09-29
25 5311-CHE-2013 POWER OF ATTORNEY 06-02-2014.pdf 2014-02-06
26 FIGURES IN.pdf 2013-11-19
26 5311-CHE-2013-Response to office action [18-11-2022(online)].pdf 2022-11-18
27 FORM 3.pdf 2013-11-19
27 5311-CHE-2013-RELEVANT DOCUMENTS [18-11-2022(online)].pdf 2022-11-18
28 FORM 5.pdf 2013-11-19
28 5311-CHE-2013-PETITION UNDER RULE 137 [18-11-2022(online)].pdf 2022-11-18
29 SPEC IN.pdf 2013-11-19
29 5311-CHE-2013-RELEVANT DOCUMENTS [14-08-2023(online)].pdf 2023-08-14

Search Strategy

1 SearchStrategy5311CHE2013_15-10-2018.pdf

ERegister / Renewals

3rd: 10 Aug 2020

From 18/11/2015 - To 18/11/2016

4th: 10 Aug 2020

From 18/11/2016 - To 18/11/2017

5th: 10 Aug 2020

From 18/11/2017 - To 18/11/2018

6th: 10 Aug 2020

From 18/11/2018 - To 18/11/2019

7th: 10 Aug 2020

From 18/11/2019 - To 18/11/2020

8th: 10 Aug 2020

From 18/11/2020 - To 18/11/2021

9th: 17 Aug 2021

From 18/11/2021 - To 18/11/2022

10th: 27 Oct 2022

From 18/11/2022 - To 18/11/2023

11th: 15 Nov 2023

From 18/11/2023 - To 18/11/2024

12th: 22 Mar 2024

From 18/11/2024 - To 18/11/2025

13th: 27 Oct 2025

From 18/11/2025 - To 18/11/2026